|
protein G-based affinity purification method
|
BAO_0002604 |
|
|
antigen-based affinity purification method
|
BAO_0002605 |
|
|
capsaicin receptor antagonist
|
CHEBI_70774 |
|
|
protein A-based affinity purification method
|
BAO_0002606 |
|
|
protein A/G-based affinity purification method
|
BAO_0002607 |
|
|
bone development disease
|
DOID_0080006 |
|
|
shortened neurite phenotype
|
BAO_0170028 |
|
|
rounded cell phenotype
|
BAO_0170029 |
|
|
apoptotic cell phenotype
|
BAO_0170015 |
|
|
dying cell phenotype
|
BAO_0170013 |
|
|
cell cycle phase phenotype
|
BAO_0170016 |
|
|
necrotic cell phenotype
|
BAO_0170014 |
|
|
regenerating neuron
|
BAO_0170011 |
|
|
dead cell phenotype
|
BAO_0170012 |
|
|
developing neuron
|
BAO_0170010 |
|
|
categorical purity
|
BAO_0002619 |
|
|
purity
|
BAO_0002618 |
|
|
PPAR modulator
|
CHEBI_70781 |
|
|
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor
|
CHEBI_50390 |
|
|
EC 1.6.5.* (oxidoreductase acting on NADH or NADPH with a quinone or similar as acceptor) inhibitor
|
CHEBI_76866 |
|
